tert-Butyl 3-aminopyridine-4-carboxylate, 95+%, 250mg

2-Aminopent-4-ynoic acid, 95.0%, 5g

4-Methyltetrahydro-2H-pyran-4-ol, 95.0%, 250mg

Dodecylcyclohexane, 98.0%, 1g

ACETIC ACID (2R,3R,4R,5R)-3,4-DIACETOXY-5-(2-AMINO-6-CHLORO-PURIN-9-YL)-TETRAHYDRO-FURAN-2-YLMETHYL ESTER, 95%, 5g

5-Fluoro-2-hydroxy-3-iodobenzamide, 97%, 1g

1-Propanaminium, N,N,N-trimethyl-2,3-bis[[(9Z)-1-oxo-9-octadecenyl]oxy]-, chloride (1:1), 98%, 250mg

2-[(TERT-BUTOXYCARBONYL)AMINO]-3-(3-FLUOROPHENYL)PROPANOIC ACID, 95.0%, 1g

Plan PLMi 10x/0,25 objetivo IOS corregido al infinito. Distancia de trabajo 20,2 mm

4,6-Dichloro-2-(o-tolyl)pyrimidine, 250mg

1-(4-nitrophenyl)ethanol, 5g

5-Bromo-2-(difluoromethyl)-1,3-difluorobenzene, 98.0%, 250mg

Chenodeoxycholic acid, 95.0%, 25g